JP Patent

JP7477846B2 — Ｎを含むヘテロアリール誘導体およびこれを有効成分として含むがんの予防または治療用薬学的組成物

Assigned to Voronoi Inc · Expires 2024-05-02 · 2y expired

What this patent protects

Patent listed against Verzenio.

Drugs covered by this patent

Verzenio (abemaciclib) · Eli Lilly

Patent Metadata

Patent number: JP7477846B2
Jurisdiction: JP
Classification: —
Expires: 2024-05-02
Drug substance claim: No
Drug product claim: No
Assignee: Voronoi Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.